Abstract:The mechanism by which GPCRs (G-protein-coupled receptors) undergo activation is believed to involve conformational changes following agonist binding. We have used photoaffinity labelling to identify domains within GPCRs that make contact with various photoreactive ligands in order to better understand the activation mechanism. Here, a series of four agonist {[Bpa1]U-II (Bpa is p-benzoyl-L-phenylalanine), [Bpa2]U-II, [Bpa3]U-II and [Bpa4]U-II} and three partial agonist {[Bpa1Pen5D-Trp7Orn8]U-II (Pen is penicil… Show more
“…The presence of a binding site in rat UII ECL3 is confirmed by photolabeling data (Holleran et al, 2007). However, it is not yet established whether this is a transient surface interaction that precedes a deeper set of interactions into the TMD bundle leading to receptor activation.…”
“…The presence of a binding site in rat UII ECL3 is confirmed by photolabeling data (Holleran et al, 2007). However, it is not yet established whether this is a transient surface interaction that precedes a deeper set of interactions into the TMD bundle leading to receptor activation.…”
“…The most conserved residues of each TMD are circled in bold. Residues of the UT receptor that are important for UII binding are in dark gray (Boucard et al, 2003;Holleran et al, 2007), and those that are important for internalization are in black with white lettering (Proulx et al, 2005). Putative Asn-glycosylation sites (Asn UT-Dependent Activation of ERK1/2 Involves Both PKC and Transactivation of the EGF Receptor.…”
“…Out of the top five models predicted by I-TASSER, we selected the model that was the most appropriate to allow the insertion of UII in the rUT receptor binding pocket (model 1, C-score = 0.24). Previous modeling done by us was used as the basis for the initial UII peptide orientation within the binding pocket [34,42]. The GROMACS software suite [43] was used with the OPLS/AA forcefield [44][45][46] and GBSA implicit solvent model [47] to perform potential energy minimization and a molecular dynamic simulation of the UII/rUT receptor complex.…”
Section: Molecular Modelingmentioning
confidence: 99%
“…The GROMACS software suite [43] was used with the OPLS/AA forcefield [44][45][46] and GBSA implicit solvent model [47] to perform potential energy minimization and a molecular dynamic simulation of the UII/rUT receptor complex. Distance restraints based on previous photolabeling results [42,48] and docking experiments [49] were used to guide and orient UII docking inside the binding pocket. The distance restraints were implemented in the topology file using r0 = 0 Å , r1 = 7 Å and r2 = 12 Å between the Cb atoms of the corresponding residues, with a force constant of 3000 kJ/mol/ nm 2 .…”
The vasoactive urotensin-II (UII), a cyclic undecapeptide widely distributed in cardiovascular, renal and endocrine systems, specifically binds the UII receptor (UT receptor), a G protein-coupled receptor (GPCR). The involvement of this receptor in numerous pathophysiological conditions including atherosclerosis, heart failure, hypertension, renal impairment and diabetes potentially makes it an interesting therapeutic target. To elucidate how UII binds the UT receptor through the identification of specific residues in transmembrane domains (TM) one (TM1) and two (TM2) that are involved in the formation of the receptor's binding pocket, we used the substituted-cysteine accessibility method (SCAM). Each residue of TM1 (V49((1.30)) to M76((1.57))) and TM2 (V88((2.41)) to H117((2.70))) was mutated, one by one, to a cysteine. The resulting mutants were then expressed in COS-7 cells and subsequently treated with the sulfhydryl-specific alkylating agent methanethiosulfonate-ethylammonium (MTSEA). MTSEA treatment resulted in a significant binding inhibition of (125)I-UII to mutant I54C((1.35)) in TM1 and mutants Y100C((2.53)), S103C((2.56)), F106C((2.59)), I107C((2.60)), T110C((2.63)) and Y111C((2.64)) in TM2. These results identify key structural residues in TM1 and TM2 that participate in the formation of the UT receptor binding pocket. Together with previous SCAM analysis of TM3, TM4, TM5, TM6 and TM7, these results have led us to identify residues within all 7 TMs that participate in UT's binding pocket and have enabled us to propose a model of this receptor's orthosteric binding site.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.